Every Form 4 that Columbia Financial, Inc. (CLBK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CLBK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLBK filings page.
Columbia Financial, Inc. (CLBK) reported that SEVP & Chief Risk Officer John Klimowich acquired 59.1208 shares of Common Stock on September 18, 2026, as a grant under the Columbia Bank Stock Based Deferral Plan at $11.58 per share, held indirectly through a stock-based deferral plan. Following this grant, he holds 20,728.4124 shares in that deferral plan and additional Common Stock through direct holdings, a 401(k), an ESOP, SERP, and several stock award vehicles. He also holds multiple stock option positions on CLBK shares with exercise prices between $7.10 and $8.31, and no Rule 10b5-1 trading plan is reported.
Columbia Financial, Inc. (CLBK) reported that President and CEO Thomas J. Kemly acquired additional common stock-equivalent interests on September 18, 2026 through a stock-based deferral arrangement. He received 160.4222 units of phantom stock, valued at $11.58 per unit, credited on a non‑discretionary basis to a rabbi trust under the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Following this award, his interest in that deferral plan totals 154,796.7866 stock units, which will be settled in shares of common stock upon distribution. The filing also lists substantial existing direct and indirect holdings of Columbia Financial common stock and several series of stock options granted under the 2019 Equity Incentive Plan, with exercise prices between $7.10 and $8.31 and expirations from 2029 to 2036. No Rule 10b5-1 trading plan is reported.
Columbia Financial, Inc. (CLBK) reported that SEVP & Chief Risk Officer John Klimowich acquired 58.5145 shares of common-stock-equivalent phantom stock on September 4, 2026 at $11.70 per share through the Columbia Bank Stock Based Deferral Plan, held in a rabbi trust and to be settled in shares upon distribution.
After this award, his indirect deferral-plan balance is 20,669.292 shares, alongside substantial vested and unvested stock options with exercise prices between $7.10 and $8.31, and additional direct and indirect common stock holdings in retirement and stock award programs; no Rule 10b5-1 trading plan is reported for this transaction.
Columbia Financial, Inc. (CLBK) reports that President & CEO Thomas J. Kemly received an award of about 159 shares of Common Stock on September 4, 2026 at $11.70 per share, credited as phantom stock under the Columbia Bank Stock Based Deferral Plan and held indirectly through a rabbi trust. Following this award, he indirectly holds about 154,636 share-equivalent units in that plan, plus substantial direct and indirect Common Stock holdings and multiple stock option grants with exercise prices between $7.10 and $8.31 per share. No Rule 10b5-1 trading plan is reported and no open-market purchases or sales are shown.
Columbia Financial, Inc. (symbol: CLBK) is the issuer of record for a Form 4 filing submitted to the SEC.
Columbia Financial, Inc. (CLBK) director Noel R. Holland reported activity in the company’s common stock on September 3, 2026. He purchased 20 shares in an open-market or private transaction at $11.68 per share and on the same day made a bona fide gift of 20 shares, resulting in no net change in his share count from these two transactions.
He continues to hold stock options giving the right to acquire 183,246 shares of common stock at an exercise price of $7.10 per share, expiring July 23, 2029; these options are fully vested and exercisable. Indirect holdings include 29,817.9802 shares through a stock-based deferral plan, 109,316 shares through a SEP-IRA, and 6,494 shares through stock awards under the 2019 Equity Incentive Plan that vest in one year on March 12, 2027. No transactions are reported as having been made under a Rule 10b5-1 trading plan.
Columbia Financial, Inc. (CLBK) reported that EVP & CIO Manesh Balachandran received a grant/award acquisition of 9.6781 shares of Common Stock on August 26, 2026, credited under a stock-based deferral plan at $11.62 per share, described as phantom stock dividends exempt under Rule 16b-3. Following this award, indirect holdings in the stock-based deferral plan total 2,258.7747 shares. The reporting officer also holds multiple stock option positions on CLBK common stock with exercise prices between $7.25 and $9.34 and expirations from 2032 to 2036, plus 16,871 phantom stock units that are economically equivalent to CLBK shares but will be settled in cash.
Columbia Financial, Inc. (CLBK) reports that SEVP & Head of Consumer Banking Allyson Katz Schlesinger had exempt acquisitions of common stock on August 26, 2026. She received 128.207 shares of phantom stock dividends at $11.62 per share through a stock-based deferral plan and 44 dividend shares at $11.62 through the Savings Income Maintenance Plan, both reported as indirect ownership under Rule 16b-3 exemptions. Following these, her indirect holdings in those plans are 29,923.612 and 10,347 shares, respectively. She also reports direct ownership of 192,490 common shares and multiple indirect holdings through a 401(k), ESOP, SERP, and performance-based stock award programs, plus several stock option grants under the 2019 Equity Incentive Plan with exercise prices between $7.10 and $8.31 and expirations from 2029 to 2036.
Columbia Financial, Inc. (symbol: CLBK) is the issuer of record for a Form 4 filing submitted to the SEC.
Columbia Financial, Inc. (CLBK) reported that executive Lewis Oliver Edward Jr., SEVP & Head Commercial Banking, acquired additional indirect interests in common stock on August 26, 2026 through exempt plan-related awards. These include 46.432 phantom-stock dividend units at $11.62 per share under a stock-based deferral plan and 6 shares at $11.62 through the Savings Income Maintenance Plan, all exempt under Rule 16b-3. The filing also details his direct holding of 65,296 common shares, multiple indirect plan holdings, and several stock option grants under the 2019 Equity Incentive Plan with exercise prices between $7.25 and $8.31 and expirations from 2029 to 2036.
Columbia Financial, Inc. (CLBK) director Noel R. Holland reported an automatic acquisition of 127.7547 shares-equivalent of common stock on August 26, 2026, as phantom stock dividends under the Columbia Bank Stock Based Deferral Plan at a reference value of $11.62 per unit. Following this award, Holland holds 29,817.9802 indirect units in the deferral plan, 80,797 directly held common shares, 109,316 common shares indirectly through a SEP-IRA, and 6,494 common shares indirectly via Stock Award V. Holland also holds fully vested stock options covering 183,246 shares of common stock at an exercise price of $7.10 per share, expiring July 23, 2029.
Columbia Financial, Inc. (CLBK) reported that President & CEO Thomas J. Kemly indirectly acquired additional common stock on August 26, 2026 through exempt awards. He received 661.183 phantom-stock dividend units under a stock-based deferral plan and 392 dividend shares under the Savings Income Maintenance Plan, both referenced at $11.62 per share, increasing indirect plan holdings. The filing also lists his existing direct and indirect common stock and stock option positions, including multiple option grants under the 2019 Equity Incentive Plan with exercise prices between $7.10 and $8.31 per share.
Columbia Financial, Inc. (CLBK) reported that SEVP & Chief Risk Officer John Klimowich acquired additional indirect common stock interests on August 26, 2026 through exempt, plan-related awards. These included 88.059 phantom-stock dividend shares at $11.6200 per share under a stock-based deferral plan and 39.0000 shares at $11.6200 per share under a savings income maintenance plan. The filing also lists his existing direct and indirect common stock holdings across 401(k), ESOP, SERP and stock award vehicles, plus multiple stock option grants under the 2019 Equity Incentive Plan with exercise prices between $7.1000 and $8.3100 and significant remaining underlying shares.
Columbia Financial, Inc. (CLBK) reported that director Elizabeth E. Randall received a grant of 211.6385 phantom stock dividends on August 26, 2026, tied to Common Stock at a reference value of $11.62 per share under a stock-based deferral plan, held indirectly. Following this, her deferral-plan balance is 49,396.2812 common-share equivalents. She also reports 105,490 shares held directly, 97,783 by IRA, 26,968 by Roth IRA, 6,494 shares in a Stock Award V that vests on March 12, 2027, and fully vested stock options over 137,442 shares at an exercise price of $7.10 expiring July 23, 2029.
Columbia Financial, Inc. (CLBK) reported that director and officer Dennis E. Gibney received an exempt award of 18.4910 shares of Common Stock on August 26, 2026 at a reference value of $11.62 per share, recorded as phantom stock dividends under the Columbia Bank Stock Based Deferral Plan. Following this, he holds 4,315.8050 indirect shares in that deferral plan and 376,592 direct Common shares, plus additional indirect holdings through retirement plans and awards. He also holds multiple stock option grants under the 2019 Equity Incentive Plan with exercise prices between $7.10 and $8.31 per share and expirations from 2029 to 2036, all reported as holdings rather than new option transactions.
Columbia Financial, Inc. (CLBK) reported that SEVP & Chief Risk Officer John Klimowich received an award of 58.0679 shares of Common Stock on August 21, 2026 at $11.79 per share, credited as phantom stock in a stock-based deferral plan and reported as indirect ownership. Following this grant, his balance in the Stock-Based Deferral Plan is 20,522.7185 shares. He also reports direct holdings of 145,056 Common shares, additional indirect holdings through retirement and award plans, and multiple outstanding stock option positions with exercise prices between $7.10 and $8.31 per share.
Columbia Financial, Inc. (CLBK) reported that President & CEO Thomas J. Kemly received an award of 157.5649 shares of Common Stock on August 21, 2026 under a stock-based deferral plan, at a reference value of $11.79 per share. These are held indirectly through the Columbia Bank Stock Based Deferral Plan as phantom stock settled in shares, bringing that indirect plan-related holding to 153,816.4041 shares. The filing also lists Kemly’s existing direct and indirect Common Stock holdings and several outstanding stock option grants with exercise prices between $7.10 and $8.31 per share.
Columbia Financial, Inc. director Noel R. Holland reported an acquisition of 15.7214 shares of Common Stock equivalents on August 7, 2026, as a grant/award under a stock-based deferral plan at $10.84 per share. The footnotes explain this represents phantom stock purchased on a non-discretionary basis by the trustee of a rabbi trust under the Columbia Bank Stock Based Deferral Plan, to be settled in shares upon distribution. Following this award, indirect holdings in the deferral plan total 29,690.2255 stock units. Holland also reports 80,797 directly held Common Shares, 109,316 Common Shares held indirectly via a SEP-IRA, and 6,494 Common Shares held indirectly as Stock Awards that vest on March 12, 2027. In addition, fully vested stock options remain outstanding, covering 183,246 shares of Common Stock at an exercise price of $7.10 per share, expiring July 23, 2029.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported an acquisition of 63.1568 shares of Columbia Financial common stock on August 7, 2026 at $10.84 per share. The shares represent phantom stock purchased on a non-discretionary basis in a rabbi trust under a stock-based deferral plan and will be settled in shares upon distribution.
Following this transaction, Klimowich holds 20,464.6506 indirect stock-based deferral units, along with various direct and indirect common stock holdings and multiple stock option awards with exercise prices between $7.10 and $8.31 per share.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported an award of 171.3736 units of Common Stock on August 7, 2026, at $10.84 per unit, credited as phantom stock under the Columbia Bank Stock Based Deferral Plan. This indirect position, held through a rabbi trust, increased his stock-based deferral plan balance to 153,658.8392 units. He also reports direct ownership of 588,391 shares of Common Stock and multiple indirect holdings through a 401(k), SERP, ESOP, spouse, and performance-based stock award vehicles, plus several option grants over Columbia Financial’s stock with exercise prices between $7.10 and $8.31 and expirations from 2029 to 2036.
Columbia Financial, Inc./MD/ director Jim Hobart Wainwright purchased 10,000 shares of common stock on July 20, 2026 at $10.00 per share in an open market or private transaction. Following this purchase, he directly holds 17,055 common shares.
In addition, he reports indirect holdings of 4,389 shares through an ESOP and 6,494 shares from stock awards granted under the Columbia Financial, Inc. 2019 Equity Incentive Plan, which vest in one year on March 12, 2027.
Columbia Financial, Inc./MD/ director Michael Massood Jr. reported purchasing 25,000 shares of Common Stock of CLBK on July 20, 2026 at $10.00 per share, in open-market or private transactions executed under a Rule 10b5-1 trading plan. The purchases were made indirectly through an IRA (10,000 shares, bringing that account to 57,044 shares) and a Roth IRA (15,000 shares, bringing that account to 93,063 shares). He also reports direct ownership of 94,613 Common shares, 6,494 indirectly held shares from Stock Awards under the 2019 Equity Incentive Plan that vest on March 12, 2027, and fully vested stock options on 183,246 shares at an exercise price of $7.10 expiring July 23, 2029.
Columbia Financial, Inc. executive Lewis Oliver Edward Jr, SEVP & Head Commercial Banking, reported open-market purchases of 15,000 shares of common stock on 2026-07-20 at $10.00 per share, split between 500 directly held shares and 14,500 acquired through a 401(k). After these trades, he reports 65,296 directly held shares plus additional indirect holdings in benefit and award plans, and maintains several option grants under the 2019 Equity Incentive Plan with exercise prices between $7.25 and $8.31. The Rule 10b5-1 checkbox is not marked, indicating these purchases were not made pursuant to an affirmed trading plan.
Columbia Financial, Inc. director Elizabeth E. Randall reported buying a total of 49,980 shares of common stock on July 20, 2026 at $10.00 per share across direct, Roth IRA, and stock-based deferral plan accounts. Following these transactions, she held 105,490 direct shares, plus indirect common stock holdings and fully vested stock options for 137,442 shares at a $7.10 exercise price expiring July 23, 2029.
Lucy Sorrentini, a director of Columbia Financial, Inc., purchased 20,000 shares of Common Stock on July 20, 2026 at $10.00 per share, held indirectly through an IRA, bringing that IRA position to 20,000 shares. She also reports 32,716 shares held directly, 16,896 shares held through a Stock-Based Deferral Plan, and 6,494 shares held via Stock Awards granted under the 2019 Equity Incentive Plan that vest in one year on March 12, 2027. The Rule 10b5-1 checkbox is not marked as a trading plan.
Columbia Financial, Inc. executive Allyson Katz Schlesinger, SEVP & Head of Consumer Banking, purchased a total of 50,000 shares of Common Stock of CLBK on July 20, 2026 at $10.00 per share, split between 44,400 directly held shares and 5,600 shares acquired through a 401(k) plan. Following these transactions, she directly holds 192,490 Common shares and also has various indirect Common Stock holdings through stock-based deferral, SERP, ESOP, SIM, and stock award vehicles, as well as multiple outstanding stock option positions with exercise prices between $7.10 and $8.31.
Columbia Financial, Inc. director James Michael Kuiken reported purchasing 10,000 shares of common stock on July 20, 2026 at $10.00 per share, held indirectly through an IRA. Following this purchase, he reported 10,000 indirect IRA shares, 35,356 directly held shares, and 6,494 additional indirect shares as stock awards that vest on March 12, 2027 under the 2019 Equity Incentive Plan.